Back to Search Start Over

Sec22b is a critical and non-redundant regulator of plasma cell maintenance

Authors :
Amélie Bonaud
Laetitia Gargowitsch
Simon M. Gilbert
Elanchezhian Rajan
Pablo Canales-Herrerias
Daniel Stockholm
Nabila F. Rahman
Mark O. Collins
Hakan Taskiran
Danika L. Hill
Andres Alloatti
Nagham Alouche
Stéphanie Balor
Vanessa Soldan
Daniel Gillet
Julien Barbier
Françoise Bachelerie
Kenneth G. C. Smith
Julia Jellusova
Pierre Bruhns
Sebastian Amigorena
Karl Balabanian
Michelle A. Linterman
Andrew A. Peden
Marion Espéli
Institut de Recherche Saint-Louis - Hématologie Immunologie Oncologie (Département de recherche de l’UFR de médecine
ex- Institut Universitaire Hématologie-IUH) (IRSL)
Université Paris Cité (UPCité)
Microenvironnement des niches tumorales (CNRS GDR 3697 Micronit )
Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)
Hopital Saint-Louis [AP-HP] (AP-HP)
Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)
Inflammation, microbiome, immunosurveillance (MI2)
Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris-Saclay
University of Cambridge [UK] (CAM)
University of Sheffield [Sheffield]
Anticorps en thérapie et pathologie - Antibodies in Therapy and Pathology
Institut Pasteur [Paris] (IP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris Cité (UPCité)
École Pratique des Hautes Études (EPHE)
Université Paris sciences et lettres (PSL)
Centre de Recherche Saint-Antoine (CRSA)
Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU)
School of Psychology [Cardiff University]
Cardiff University
Technische Universität München = Technical University of Munich (TUM)
Max Planck Institute of Immunobiology and Epigenetics (MPI-IE)
Max-Planck-Gesellschaft
The Babraham Institute [Cambridge, UK]
Monash University [Melbourne]
Immunité et cancer (U932)
Institut Curie [Paris]-Institut National de la Santé et de la Recherche Médicale (INSERM)
Universidad Nacional de Rosario [Santa Fe]
Centre de Biologie Intégrative (CBI)
Université Toulouse III - Paul Sabatier (UT3)
Université de Toulouse (UT)-Université de Toulouse (UT)-Centre National de la Recherche Scientifique (CNRS)
Service d'Ingénierie Moléculaire pour la Santé (ex SIMOPRO) (SIMoS)
Médicaments et Technologies pour la Santé (MTS)
Université Paris-Saclay-Direction de Recherche Fondamentale (CEA) (DRF (CEA))
Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement (INRAE)-Université Paris-Saclay-Direction de Recherche Fondamentale (CEA) (DRF (CEA))
Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement (INRAE)
ANR-19-CE15-0019,PC-SEC,Impact des SNARE sur la biologie des plasmocytes(2019)
ANR-14-ACHN-0008,AUTO-PLASMO,Analyse integrative de la biologie des plasmocytes normaux et pathologiques(2014)
ANR-17-CE14-0019,OSTEOVALYMPH,Autocrinie et paracrinie de l'axe de signalisation CXCL12/CXCR4-CXCR7 dans la niche ostéo-vasculaire: impact sur la spécification et l'engagement lymphoïde des cellules souches hématopoïétiques(2017)
ANR-18-CE15-0001,Autoimmuni-B,Etude de la rupture de tolérance dans une maladie humaine autoimmune médiée par les lymphocytes B(2018)
The study was supported by the Laboratory of Excellence in Research on Medication and Innovative Therapeutics (LabEx LERMIT) (M.E. and K.B.)
an ANR JCJC grant (ANR-19-CE15-0019-01), an ANR @RAction grant (ANR-14-ACHN-0008), a 'Fondation ARC pour la recherche sur le cancer' grant (P JA20181208173), and a grant from IdEx Université Paris-Cité (ANR-18-IDEX-0001) to M.E.
and an ANR PRC grant (ANR-17-CE14-0019) and an INCa grant (PRT-K 2017) to K.B. P.B. acknowledges funding from the French National Research Agency grant ANR-18-CE15-0001 project Autoimmuni-B, by the Institut Carnot Pasteur Microbes et Santé grant ANR-11-CARN-0017-01, the Institut Pasteur, and the Institut National de la Santé et de la Recherche Médicale (INSERM). M.A.L. is supported by Biotechnology and Biological Sciences Research Council (BBS/E/B/000C0427, BBS/E/B/000C0428, and the Campus Capability Core Grant to the Babraham Institute). A.A.P. and M.O.C. were supported by a grant from the Biotechnology and Biological Sciences Research Council (BB/L022389/1). D.L.H. is supported by a National Health and Medical Research Council Australia Early-Career Fellowship (APP1139911). N.A. was supported by a PhD fellowship from the French Ministry for education and by a fourth year PhD fellowship from the 'Fondation ARC pour la recherche sur le cancer.' P.C.-H. was supported partly by a stipend from the Pasteur-Paris University (PPU) International PhD program, and by a fellowship from the French Fondation pour la Recherche Médicale (FRM). K.G.C.S. was supported by the Wellcome Trust (Programme Grant Number 083650/Z/07/Z). J.J’s research is supported by the German Research Foundation project number: 419193696 and through the CRC1335. H.T. is supported through the graduate school of the Max Planck Institute for Immunobiology and Epigenetics (IMPRS-IE) and through the CRC1335. The 'EMiLy' U1160 INSERM unit is a member of the OPALE Carnot institute, The Organization for Partnerships in Leukemia (Institut Carnot OPALE, Institut de Recherche Saint-Louis, Hôpital Saint-Louis, Paris, France. Web: www.opale.org. Email: contact@opale.org).
ANR-18-IDEX-0001,Université de Paris,Université de Paris(2018)
Bonaud, Amélie [0000-0002-4153-9171]
Rajan, Elanchezhian [0000-0002-6257-3678]
Canales-Herrerias, Pablo [0000-0002-1865-6476]
Stockholm, Daniel [0000-0002-5069-5256]
Collins, Mark O [0000-0002-7656-4975]
Taskiran, Hakan [0000-0002-2690-3887]
Alloatti, Andres [0000-0003-0555-0653]
Gillet, Daniel [0000-0003-0477-3599]
Bruhns, Pierre [0000-0002-4709-8936]
Balabanian, Karl [0000-0002-0534-3198]
Linterman, Michelle A [0000-0001-6047-1996]
Peden, Andrew A [0000-0003-0144-7712]
Espéli, Marion [0000-0001-5005-1664]
Apollo - University of Cambridge Repository
Source :
Proceedings of the National Academy of Sciences of the United States of America, Proceedings of the National Academy of Sciences of the United States of America, 2023, 120 (2), pp.e2213056120. ⟨10.1073/pnas.2213056120⟩
Publication Year :
2023
Publisher :
HAL CCSD, 2023.

Abstract

Despite the essential role of plasma cells in health and disease, the cellular mechanisms controlling their survival and secretory capacity are still poorly understood. Here, we identified the soluble N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE) Sec22b as a unique and critical regulator of plasma cell maintenance and function. In the absence of Sec22b, plasma cells were hardly detectable and serum antibody titers were dramatically reduced. Accordingly, Sec22b -deficient mice fail to mount a protective immune response. At the mechanistic level, we demonstrated that Sec22b contributes to efficient antibody secretion and is a central regulator of plasma cell maintenance through the regulation of their transcriptional identity and of the morphology of the endoplasmic reticulum and mitochondria. Altogether, our results unveil an essential and nonredundant role for Sec22b as a regulator of plasma cell fitness and of the humoral immune response.

Details

Language :
English
ISSN :
00278424 and 10916490
Database :
OpenAIRE
Journal :
Proceedings of the National Academy of Sciences of the United States of America, Proceedings of the National Academy of Sciences of the United States of America, 2023, 120 (2), pp.e2213056120. ⟨10.1073/pnas.2213056120⟩
Accession number :
edsair.doi.dedup.....0f62eb6890c17956c3a9822f5a059b5a
Full Text :
https://doi.org/10.1073/pnas.2213056120⟩